http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Zhenmin Liu,Junwei Wang,Mao-qing Kang,Ning Yin,Xin-kui Wang,Yisheng Tan,Yulei Zhu 한국공업화학회 2015 Journal of Industrial and Engineering Chemistry Vol.21 No.1
MgAl hydrotalcite synthesized via co-precipitation method from magnesium and aluminum nitrateswas calcined to produce Mg4AlO5.5 mixed oxides. The oxides were modified by introducing LiNO3 andapplied to the synthesis of glycerol carbonate from glycerol and dimethyl carbonate. The research resultsindicated that LiNO3/Mg4AlO5.5 was an efficient catalyst for the synthesis of glycerol carbonate. The fullconversion of glycerol and 96.28% yield of glycerol carbonate were obtained after reacting at 80 8C for1.5 h in the presence of LiNO3/Mg4AlO5.5. The structure and properties of the catalysts were studied bymeans of XRD, TGA, BET, CO2-TPD and Hammett indicator method. It was found that the basic strengthand the basicity of the catalysts were enhanced after addition of LiNO3. Over Mg4AlO5.5 oxides, LiNO3 waseasily converted to LiAlO2 which constituted new strong basic sites. Too high basic strength and basicityof catalysts may improve the conversion of glycerol at the cost of GC selectivity reduction.
Synthesis of Hydroxylactams and Esters Derived from Thalidomide and Their Antitumor Activities
Guanglong Sun,Xiangchao Liu,Heng Zhou,Zenglu Liu,Zhenmin Mao 대한화학회 2014 Bulletin of the Korean Chemical Society Vol.35 No.5
A novel and convenient route for the synthesis of a series of thalidomide derivatives is described. Compound 2 was cyclized with different amines under alkaline condition to obtain 4-nitro substituted phthalimidines 3a-d. Hydroxylactams 4a-d were produced via bromination and hydroxylation. Different acyl chlorides were reacted with hydroxylactams to provide the desired esters 5a-d. All compounds were evaluated by MTT assay for their inhibitory activities against HCT-116, MG-63, MCF-7, HUVEC and HMVEC cell lines in vitro. Most of them showed no obvious cytotoxic effect on normal human cells, compounds 4a-d, 5a2, 5a4, 5a5, 5b2, 5c2 and 5d2 exhibited potent antitumor activities, among which compounds 5a2 and 5b2 were more effective than 5-FU.
Synthesis of Hydroxylactams and Esters Derived from Thalidomide and Their Antitumor Activities
Sun, Guanglong,Liu, Xiangchao,Zhou, Heng,Liu, Zenglu,Mao, Zhenmin Korean Chemical Society 2014 Bulletin of the Korean Chemical Society Vol.35 No.5
A novel and convenient route for the synthesis of a series of thalidomide derivatives is described. Compound 2 was cyclized with different amines under alkaline condition to obtain 4-nitro substituted phthalimidines 3a-d. Hydroxylactams 4a-d were produced via bromination and hydroxylation. Different acyl chlorides were reacted with hydroxylactams to provide the desired esters 5a-d. All compounds were evaluated by MTT assay for their inhibitory activities against HCT-116, MG-63, MCF-7, HUVEC and HMVEC cell lines in vitro. Most of them showed no obvious cytotoxic effect on normal human cells, compounds 4a-d, $5a_2$, $5a_4$, $5a_5$, $5b_2$, $5c_2$ and $5d_2$ exhibited potent antitumor activities, among which compounds $5a_2$ and $5b_2$ were more effective than 5-FU.
Xiaoping Zhan,Lan Lan,Yuankui Zhang,Jian Chen,Kai Zhao,Shuai Wang,Yuxuan Xin,Zhenmin Mao 대한화학회 2016 Bulletin of the Korean Chemical Society Vol.37 No.2
A new series of 3-substituted 4-(4-methyloxy phenyl)-1H-pyrrole derivatives were synthesized and biologically evaluated for potential anticancer activity. Fifteen targeted compounds showed high selectivity toward normal cells and cancer cells: that is, all targeted compounds had no obvious cytotoxicity toward normal human cells (HUVEC and NIH/3T3), but some compounds exhibited broad-spectrum proliferation inhibitory activity against the screened cancer cell lines. Among these pyrrole derivatives, compounds 3b and 3o showed potent anticancer activity against the MG-63 cell line, with IC50 values of 14.9 and 12.7 μM, respectively. Other pyrrole derivatives also showed promising proliferation inhibitory activity, including compound 3d against A375 (IC50 = 18.6 μM), compound 3f and 3j against MGC80-3 (IC50 = 19.9 μM), and compound 3o against MGC80-3 (IC50 = 11.9 μM). Because the developed pyrrole derivatives showed strong anticancer activity and high selectivity, this new series of pyrrole derivatives could be considered as promising lead compounds for further development of potent and safe anticancer agents.